| Literature DB >> 29744409 |
Xiaoxi Yang1, Afrah Al Hegy1, Eric R Gauthier1, Joy Gray-Munro1.
Abstract
In the last decade, the use of magnesium and its alloys as biodegradable implant materials has become increaEntities:
Keywords: Biodegradable; Biomimetic; Cell adhesion; Magnesium alloys; Organosilane; RGD peptide; Surface modification
Year: 2017 PMID: 29744409 PMCID: PMC5935023 DOI: 10.1016/j.bioactmat.2017.01.001
Source DB: PubMed Journal: Bioact Mater ISSN: 2452-199X
Fig. 1Schematic representation of the surface modification strategy. Steps 1 and 2 illustrate the formation of the organosilane coating on the surface. Step 3 and 4 show the reaction of the heterobifunctional crosslinker with surface thiols and peptide amine groups. Step 5 is a schematic diagram of the final modified surface.
Composition of coating solutions.
| Coating solution | % MPTS (v/v) | % TEOS (v/v) | % H2O (v/v) | % CH3OH (v/v) | Mol % MPTS |
|---|---|---|---|---|---|
| MPTS/TEOS = 1 | 4% | 4% | 12% | 80% | 55% |
| MPTS/TEOS = 3 | 6% | 2% | 12% | 80% | 78% |
| MPTS | 8% | 0% | 12% | 80% | 100% |
Fig. 2spectra of organosilane coatings deposited on Mg AZ31 substrates from three different coating solutions.
Fig. 3XPS S/Si atomic % and water contact angle analysis of organosilane coatings deposited on Mg AZ31 substrates from three different coating solutions. XPS data are the average ± standard deviation of 3 measurements. Contact angles are the average ± standard deviation of a minimum of 6 measurements.
Fig. 410 × 10 µm scale AFM images of organosilane coatings deposited on Mg AZ31 substrates from three different coating solutions before and after treatment with 10 nm gold nanoparticles (AuNP’s). a) as-deposited coating MPTS/TEOS = 1, b) as-deposited coating MPTS/TEOS = 3, c) as-deposited coating MPTS, d) AuNP treated coating MPTS/TEOS = 1, e) AuNP treated coating MPTS/TEOS = 3 and f) AuNP treated coating MPTS.
Mixed organosilane coating thickness.
| Type of coating | Measured thickness |
|---|---|
| MPTS/TEOS = 1 | 696 ± 58 |
| MPTS/TEOS = 3 | 658 ± 43 |
| MPTS | 938 ± 85 |
Fig. 5Amount of magnesium dissolved in a 0.9% NaCl (w/v) solution as a function of immersion time for uncoated and coated Mg AZ31 samples. Data are the average ± standard deviation of at least 3 samples.
Fig. 6XPS analysis of the RGD modified coatings. a) N/S atomic % for organosilane coatings deposited on Mg AZ31 substrates from three different coating solutions and b) high resolution N 1s spectrum for RGD modified MPTS coating. Quantitative data are the average ± standard deviation of 3 measurements.
Fig. 7Results of the cell adhesion and cell proliferation tests. a) number of Saos-2 cell adhered on uncoated Mg AZ31, organosilane coated Mg AZ31 and RGD modified organosilane coated Mg AZ31 surfaces after a 3 hour incubation period. Uncoated Mg AZ31 and organosilane coatings without RGD modification were applied as control groups. Data are the average ± standard deviation of 4 samples (2 replicates of 2 independent experiments) and b) Saos-2 cell proliferation numbers on uncoated Mg AZ31, organosilane coated Mg AZ31 and RGD modified organosilane coated Mg AZ31 surfaces after a 10 day proliferation time. Uncoated Mg AZ31, organosilane coatings without RGD modification were applied as control groups. In addition cell proliferation in the absence of any magnesium substrate (bare well) was measured Data are the average ± standard deviation of 4 samples (2 replicates of 2 independent experiments).* indicates p<0.05 between uncoated Mg and the sample. † indicates p<0.05 between organosilane coated Mg and organosilane/RGD coated Mg.